| 1 |
28716728 | Cytochrome P450 3A selectively affects the pharmacokinetic interaction between erlotinib and docetaxel in rats. | 2017 Nov 1 |
3 |
| 2 |
24329500 | Effect of triacontanol on the pharmacokinetics of docetaxel in rats associated with induction of cytochrome P450 3A1/2. | 2014 Jul |
1 |
| 3 |
22067009 | Effects of cysteine on the pharmacokinetics of docetaxel in rats with protein-calorie malnutrition. | 2012 May |
1 |
| 4 |
22201019 | Effect of dose and dosage interval on the oral bioavailability of docetaxel in combination with a curcumin self-emulsifying drug delivery system (SEDDS). | 2012 Sep |
1 |
| 5 |
22936118 | Comparative pharmacokinetic study of paclitaxel and docetaxel in streptozotocin-induced diabetic rats. | 2012 Nov |
1 |
| 6 |
20663044 | Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats. | 2010 Aug |
1 |
| 7 |
20727390 | Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin. | 2010 Oct 31 |
2 |
| 8 |
11561777 | Increased activity of CYP3A enzyme in primary cultures of rat hepatocytes treated with docetaxel: comparative evaluation with paclitaxel. | 2001 Aug |
8 |